Q3 2019

Filed Nov 7, 2019 · 10-Q · 38 days after period end · 0001104659-19-060851

Q3 2019 · 10-Q

Revenue

$0.00

−100.0% vs Q3 2018

Net Income

-$3.43M

N/M vs Q3 2018

EPS Diluted

-$1.15

N/M vs Q3 2018

Operating Income-$3,451,274N/M

Operating Cash Flow

Same quarter

Metric	Q3 2019	Q3 2018	Q3 2017	Q3 2016
Revenue	$0.00	$314.50K	$74.70K	$274.29K
Net Income	-$3.43M	-$3.12M	-$4.14M	-$3.38M
EPS Diluted	-$1.15	-$1.08	-$0.24	-$0.36

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kiora Pharmaceuticals Inc · CIK 1372514 · Engraved from SEC EDGAR